Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise | 27 May 2016 |
| Bavarian Nordic A/S - Articles of Association | 27 May 2016 |
| Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations | 26 May 2016 |
| Bavarian Nordic Announces Positive Top Line Results from a Phase 1 Trial of a Novel, Broad Spectrum RSV Vaccine in Healthy Adult and Elderly Populations | 23 May 2016 |
| Bavarian Nordic Announces USD 100 Million Supply Contract for IMVAMUNE Smallpox Vaccine with the U.S. Government | 19 May 2016 |